What is Enovis' operating income?

Enovis' total operating income in 2025 was -$1.12 billion, based on the following breakdown: Total Gross Profit: $1.35 billion Total Operating Expenses: $2.47 billion

Enovis (ENOV) Financials

$21.52 -0.42 (-1.89%)

Closing price 03:58 PM Eastern

Extended Trading

$21.56 +0.03 (+0.14%)

As of 04:10 PM Eastern

Compare

Annual Income Statements for Enovis

This table shows Enovis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	168	128	151	140	-528	43	72	-13	-33	-825	-1,184
Consolidated Net Income / (Loss)	187	145	170	154	-517	46	76	-12	-33	-825	-1,184
Net Income / (Loss) Continuing Operations	177	155	46	122	19	-74	-102	-38	-54	-827	-1,182
Total Pre-Tax Income	218	207	49	92	50	-119	-122	-2.07	-67	-823	-1,159
Total Operating Income	266	237	136	152	204	-66	-63	-71	-66	-776	-1,124
Total Gross Profit	1,072	992	672	729	1,401	604	778	869	991	1,181	1,345
Total Revenue	3,434	3,186	1,937	2,193	3,327	1,121	1,426	1,563	1,707	2,108	2,248
Operating Revenue	3,434	3,186	1,937	2,193	3,327	1,121	1,426	1,563	1,707	2,108	2,248
Total Cost of Revenue	2,363	2,193	1,266	1,464	1,926	517	649	694	716	927	903
Operating Cost of Revenue	2,363	2,193	1,266	1,464	1,926	517	649	694	716	927	903
Total Operating Expenses	806	756	536	578	1,197	670	840	941	1,056	1,956	2,469
Selling, General & Admin Expense	748	697	501	549	1,132	515	666	773	830	1,027	1,070
Research & Development Expense	-	-	-	-	-	34	49	61	75	91	120
Amortization Expense	-	-	-	-	-	103	117	126	134	166	174
Other Operating Expenses / (Income)	-	-	-	-	-	-	-	-	0.00	0.00	46
Impairment Charge	1.49	0.24	-	-	-	-	-	0.00	0.00	645	1,050
Restructuring Charge	57	58	35	29	65	17	8.69	17	17	27	9.79
Total Other Income / (Expense), net	-48	-30	-87	-59	-153	-53	-59	69	-1.42	-47	-35
Interest Expense	48	30	40	49	120	53	59	44	27	57	35
Other Income / (Expense), net	-	-	-47	0.04	-34	0.00	0.00	11	26	9.90	-0.37
Income Tax Expense	41	52	2.48	-30	32	-45	-20	36	-13	4.49	22
Net Income / (Loss) Discontinued Operations	10	-9.56	123	33	-536	120	179	26	21	2.60	-1.91
Net Income / (Loss) Attributable to Noncontrolling Interest	19	17	18	14	11	3.15	4.62	1.53	0.53	0.68	0.82
Basic Earnings per Share	$1.35	$1.04	$1.23	$1.17	($3.89)	$0.93	$1.40	($0.25)	($0.61)	($14.93)	($20.75)
Weighted Average Basic Shares Outstanding	124.10M	122.91M	123.23M	120.29M	118.15M	118.55M	161.33M	54.33M	54.62M	56.96M	57.25M
Diluted Earnings per Share	$1.34	$1.04	$1.22	$1.16	($3.89)	$0.93	$1.40	($0.25)	($0.61)	($14.93)	($20.75)
Weighted Average Diluted Shares Outstanding	124.10M	122.91M	123.23M	120.29M	118.15M	118.55M	161.33M	54.33M	54.62M	56.96M	57.25M
Weighted Average Basic & Diluted Shares Outstanding	124.10M	122.91M	123.23M	120.29M	118.15M	118.55M	161.33M	54.33M	54.62M	56.96M	57.25M

This table shows Enovis' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/29/2023	12/31/2023	3/29/2024	6/28/2024	9/27/2024	12/31/2024	4/4/2025	7/4/2025	10/3/2025	12/31/2025	4/3/2026
Net Income / (Loss) Attributable to Common Shareholders	-2.88	2.96	-72	-19	-32	-703	-56	-37	-571	-521	-8.76
Consolidated Net Income / (Loss)	-2.84	3.08	-72	-19	-31	-703	-56	-37	-571	-520	-8.45
Net Income / (Loss) Continuing Operations	-19	3.07	-72	-18	-34	-704	-56	-36	-571	-519	-8.41
Total Pre-Tax Income	-26	7.66	-79	-27	-43	-674	-57	-26	-567	-510	0.63
Total Operating Income	-20	-5.76	-35	-44	-32	-665	-47	-17	-558	-502	6.53
Total Gross Profit	243	264	298	289	286	308	332	335	329	349	365
Total Revenue	418	455	516	525	505	561	559	565	549	576	589
Operating Revenue	418	455	516	525	505	561	559	565	549	576	589
Total Cost of Revenue	175	191	218	236	219	253	227	230	220	226	224
Operating Cost of Revenue	175	191	218	236	219	253	227	230	220	226	224
Total Operating Expenses	263	270	333	333	318	972	379	351	887	852	359
Selling, General & Admin Expense	204	211	256	264	250	258	269	267	264	270	283
Research & Development Expense	20	18	23	23	20	24	29	31	30	31	32
Amortization Expense	34	35	41	41	43	41	42	43	44	45	42
Other Operating Expenses / (Income)	-	-	0.00	0.00	0.00	-	36	10	0.00	-	0.00
Restructuring Charge	5.34	5.55	13	4.59	5.07	4.73	3.86	0.72	1.91	3.30	2.71
Total Other Income / (Expense), net	-5.01	13	-44	17	-11	-8.98	-11	-8.86	-8.38	-7.37	-5.90
Interest Expense	5.77	12	20	17	11	9.07	9.19	9.29	8.83	7.51	9.17
Other Income / (Expense), net	0.76	25	-24	34	0.20	0.09	-1.39	0.44	0.45	0.14	3.27
Income Tax Expense	-6.05	4.59	-7.40	-8.91	-9.10	30	-1.77	11	4.01	9.26	9.05
Net Income / (Loss) Discontinued Operations	17	0.01	0.00	-0.07	2.24	0.43	-0.13	-0.09	-0.04	-1.65	-0.04
Net Income / (Loss) Attributable to Noncontrolling Interest	0.04	0.12	0.16	0.13	0.26	0.14	0.26	0.19	0.23	0.14	0.31
Basic Earnings per Share	($0.05)	$0.05	($1.32)	($0.34)	($0.58)	($12.69)	($0.98)	($0.64)	($9.99)	($9.14)	($0.15)
Weighted Average Basic Shares Outstanding	54.59M	54.62M	54.85M	55.85M	55.88M	56.96M	57.12M	57.16M	57.19M	57.25M	57.56M
Diluted Earnings per Share	($0.05)	$0.05	($1.32)	($0.34)	($0.58)	($12.69)	($0.98)	($0.64)	($9.99)	($9.14)	($0.15)
Weighted Average Diluted Shares Outstanding	54.59M	54.62M	54.85M	55.85M	55.88M	56.96M	57.12M	57.16M	57.19M	57.25M	57.56M
Weighted Average Basic & Diluted Shares Outstanding	54.59M	54.62M	54.85M	55.85M	55.88M	56.96M	57.12M	57.16M	57.19M	57.25M	57.56M

This table details how cash moves in and out of Enovis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-108	24	40	-17	-135	-8.56	618	-695	21	3.34	-12
Net Cash From Operating Activities	304	247	219	226	131	302	356	-56	135	114	217
Net Cash From Continuing Operating Activities	304	247	219	226	131	302	356	-56	135	114	217
Net Income / (Loss) Continuing Operations	187	145	170	154	-517	46	76	-12	-33	-825	-1,184
Consolidated Net Income / (Loss)	187	145	170	154	-517	46	76	-12	-33	-825	-1,184
Depreciation Expense	142	137	132	142	236	246	263	220	217	285	294
Non-Cash Adjustments To Reconcile Net Income	39	30	-63	30	544	34	56	-48	30	686	1,092
Changes in Operating Assets and Liabilities, net	-64	-65	-20	-100	-132	-24	-39	-216	-79	-33	15
Net Cash From Investing Activities	-247	-82	90	-168	-1,633	-175	-320	-176	-242	-955	-179
Net Cash From Continuing Investing Activities	-247	-82	90	-168	-1,633	-175	-320	-176	-242	-955	-179
Purchase of Property, Plant & Equipment	-70	-63	-69	-70	-125	-115	-104	-105	-122	-181	-197
Acquisitions	-196	-26	-347	-291	-3,151	-70	-223	-74	-153	-770	-27
Purchase of Investments	-	-	-	-	-	-	-	0.00	-	-4.85	1.60
Sale of Property, Plant & Equipment	-	7.25	21	35	7.78	9.55	7.03	2.75	33	0.00	0.00
Divestitures	0.00	0.00	490	18	1,636	-	-	-	0.00	0.00	43
Net Cash From Financing Activities	-131	-145	-280	-47	1,369	-132	585	-465	128	847	-52
Net Cash From Continuing Financing Activities	-131	-145	-280	-47	1,369	-132	585	-465	128	847	-52
Repayment of Debt	-2,358	-1,023	-1,708	-1,123	-2,697	-996	-1,152	-2,129	-727	-542	-594
Repurchase of Common Equity	-27	-21	0.00	-200	-	-	-	0.00	0.00	-4.77	-3.50
Issuance of Debt	2,248	897	1,421	1,271	3,770	861	991	515	915	1,392	544
Issuance of Common Equity	6.05	2.21	6.94	4.70	12	3.50	745	5.81	1.78	1.87	1.32
Other Financing Activities, net	-	-	0.00	0.00	378	0.00	0.00	1,143	-62	0.00	0.00
Effect of Exchange Rate Changes	-34	4.50	12	-28	-3.07	-3.77	-2.23	2.30	0.22	-1.52	2.70
Cash Interest Paid	-	36	43	50	139	105	85	37	16	52	27
Cash Income Taxes Paid	-	77	71	97	135	59	47	31	13	11	18

This table details how cash moves in and out of Enovis' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/29/2023	12/31/2023	3/29/2024	6/28/2024	9/27/2024	12/31/2024	4/4/2025	7/4/2025	10/3/2025	12/31/2025	4/3/2026
Net Change in Cash & Equivalents	-0.36	13	30	-31	-3.63	8.37	-9.71	5.61	-10	2.77	-3.26
Net Cash From Operating Activities	31	68	-36	7.77	54	88	-1.60	48	83	89	24
Net Cash From Continuing Operating Activities	31	68	-36	7.77	54	88	-1.60	48	83	89	24
Net Income / (Loss) Continuing Operations	-2.84	3.08	-72	-19	-31	-703	-56	-37	-571	-520	-8.45
Consolidated Net Income / (Loss)	-2.84	3.08	-72	-19	-31	-703	-56	-37	-571	-520	-8.45
Depreciation Expense	55	57	73	133	71	74	71	72	74	77	73
Non-Cash Adjustments To Reconcile Net Income	-5.95	17	19	-66	6.31	646	8.23	12	559	512	10
Changes in Operating Assets and Liabilities, net	-16	-7.84	-57	-41	7.28	71	-26	0.87	20	20	-51
Net Cash From Investing Activities	-17	-59	-798	-41	-58	-58	-61	-50	-56	-13	-53
Net Cash From Continuing Investing Activities	-17	-59	-798	-41	-58	-58	-61	-50	-56	-13	-53
Purchase of Property, Plant & Equipment	-27	-28	-37	-39	-51	-53	-43	-44	-53	-56	-53
Acquisitions	-33	-21	-761	2.72	-7.23	-4.49	-19	-5.43	-2.57	-	-0.29
Purchase of Investments	-	-	-	-	-	-0.20	1.60	-	-	1.60	0.00
Net Cash From Financing Activities	-14	2.79	865	2.51	-0.15	-20	51	6.23	-37	-73	26
Net Cash From Continuing Financing Activities	-14	2.79	865	2.51	-0.15	-20	51	6.23	-37	-73	26
Repayment of Debt	-44	-451	-12	-454	-0.53	-72	-18	-50	-87	-440	-46
Issuance of Debt	30	515	880	460	-	52	72	55	50	367	72
Issuance of Common Equity	0.10	0.29	0.87	0.31	0.38	0.32	0.34	0.79	0.19	-	0.63
Other Financing Activities, net	-	-62	-4.77	-4.07	-	4.77	-3.45	-	-0.06	3.50	-0.94
Other Net Changes in Cash	-	-	-	-	-	-	1.22	-	-	-	-0.14

This table presents Enovis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	6,733	6,338	6,710	6,616	7,387	7,352	8,516	4,273	4,509	4,719	3,835
Total Current Assets	1,731	1,739	2,070	1,958	1,404	1,362	2,303	795	897	1,146	1,207
Cash & Equivalents	197	209	262	77	110	97	680	24	36	48	36
Accounts Receivable	888	839	970	387	562	517	255	267	291	407	443
Inventories, net	420	365	430	360	572	565	356	427	469	547	584
Prepaid Expenses	-	-	-	-	70	70	26	29	29	36	42
Other Current Assets	225	176	258	138	91	113	29	48	71	108	101
Plant, Property, & Equipment, net	645	505	553	327	491	487	235	237	271	405	507
Total Noncurrent Assets	4,357	4,094	4,087	4,330	5,491	5,503	5,978	3,241	3,342	3,168	2,121
Goodwill	2,818	2,351	2,539	1,498	3,203	3,315	1,934	1,984	2,061	1,693	718
Intangible Assets	996	916	1,017	628	1,719	1,663	1,154	1,111	1,127	1,317	1,237
Other Noncurrent Operating Assets	544	520	531	464	570	525	151	147	154	158	166
Total Liabilities & Shareholders' Equity	6,733	6,338	6,710	6,616	7,387	7,352	8,516	4,273	4,509	4,719	3,835
Total Liabilities	3,476	3,245	2,982	3,139	3,897	3,764	3,854	823	1,089	2,154	2,343
Total Current Liabilities	1,116	1,060	1,097	1,199	857	812	1,024	565	370	529	598
Short-Term Debt	5.79	5.41	5.77	5.02	28	27	7.70	219	0.00	20	35
Accounts Payable	569	516	587	291	360	330	155	136	132	179	188
Accrued Expenses	346	311	359	291	470	454	225	210	237	330	376
Total Noncurrent Liabilities	2,360	2,185	1,885	1,940	3,040	2,952	2,831	258	719	1,625	1,744
Long-Term Debt	1,412	1,287	1,055	1,192	2,284	2,204	2,079	40	466	1,309	1,262
Capital Lease Obligations	-	-	-	0.00	136	139	57	51	49	52	58
Other Noncurrent Operating Liabilities	948	733	830	652	619	609	122	167	204	264	425
Total Equity & Noncontrolling Interests	3,257	3,093	3,727	3,477	3,490	3,588	4,661	3,450	3,421	2,564	1,492
Total Preferred & Common Equity	3,070	2,897	3,500	3,270	3,441	3,543	4,617	3,448	3,418	2,562	1,490
Total Common Equity	3,070	2,897	3,500	3,270	3,441	3,543	4,617	3,448	3,418	2,562	1,490
Common Stock	3,199	3,200	3,228	3,058	3,446	3,478	4,544	2,926	2,901	2,973	3,048
Retained Earnings	557	685	846	992	480	517	589	576	542	-283	-1,467
Accumulated Other Comprehensive Income / (Loss)	-687	-988	-574	-780	-484	-452	-516	-53	-25	-128	-91
Noncontrolling Interest	187	196	227	207	48	44	44	1.72	2.31	2.07	2.26

This table presents Enovis' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/29/2023	3/29/2024	6/28/2024	9/27/2024	4/4/2025	7/4/2025	10/3/2025	4/3/2026
Total Assets	4,445	4,300	4,444	4,401	5,479	5,442	5,550	4,875	5,021	4,433	3,832
Total Current Assets	1,008	833	887	854	1,151	1,173	1,203	1,218	1,280	1,280	1,240
Cash & Equivalents	55	22	32	32	66	35	35	38	44	34	33
Accounts Receivable	259	281	299	277	381	395	400	436	454	432	444
Inventories, net	417	439	454	471	586	615	610	586	628	614	603
Prepaid Expenses	29	30	27	29	36	41	46	42	44	47	50
Other Current Assets	48	61	75	45	81	87	112	116	111	154	110
Plant, Property, & Equipment, net	225	246	261	260	346	378	403	426	460	486	520
Total Noncurrent Assets	3,211	3,220	3,296	3,287	3,982	3,891	3,944	3,231	3,281	2,667	2,073
Goodwill	1,960	1,987	2,034	2,027	2,415	2,353	2,394	1,733	1,781	1,219	712
Intangible Assets	1,117	1,082	1,111	1,101	1,408	1,380	1,396	1,345	1,342	1,281	1,192
Other Noncurrent Operating Assets	135	151	151	158	159	157	154	153	158	167	168
Total Liabilities & Shareholders' Equity	4,445	4,300	4,444	4,401	5,479	5,442	5,550	4,875	5,021	4,433	3,832
Total Liabilities	1,037	854	993	959	2,168	2,153	2,217	2,255	2,440	2,410	2,353
Total Current Liabilities	854	349	354	355	549	518	530	477	568	575	609
Short-Term Debt	449	0.00	0.00	0.00	20	15	20	20	20	20	35
Accounts Payable	180	152	147	125	156	160	158	188	212	199	214
Accrued Expenses	225	198	206	230	373	343	352	269	336	355	360
Total Noncurrent Liabilities	183	505	639	604	1,619	1,635	1,687	1,777	1,872	1,834	1,744
Long-Term Debt	0.00	285	400	395	1,318	1,329	1,325	1,368	1,374	1,340	1,291
Capital Lease Obligations	52	49	48	49	51	50	47	49	48	58	59
Other Noncurrent Operating Liabilities	131	171	192	160	249	255	314	361	451	437	394
Total Equity & Noncontrolling Interests	3,408	3,445	3,451	3,442	3,311	3,289	3,333	2,620	2,581	2,024	1,479
Total Preferred & Common Equity	3,407	3,443	3,449	3,440	3,308	3,286	3,330	2,618	2,578	2,021	1,477
Total Common Equity	3,407	3,443	3,449	3,440	3,308	3,286	3,330	2,618	2,578	2,021	1,477
Common Stock	2,909	2,934	2,944	2,953	2,903	2,911	2,965	3,022	3,031	3,040	3,057
Retained Earnings	614	552	542	540	470	452	420	-339	-376	-947	-1,476
Accumulated Other Comprehensive Income / (Loss)	-117	-43	-38	-53	-65	-77	-55	-65	-77	-73	-104
Noncontrolling Interest	1.51	1.93	2.12	2.11	2.42	2.52	2.88	2.45	2.77	3.00	2.57

This table displays calculated financial ratios and metrics derived from Enovis' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-25.74%	-7.24%	-39.19%	13.20%	51.73%	-66.32%	27.26%	9.60%	9.22%	23.46%	6.66%
EBITDA Growth	-30.23%	-8.25%	-40.95%	32.86%	38.36%	-55.66%	11.15%	-20.34%	11.07%	-371.67%	-72.59%
EBIT Growth	-35.14%	-10.83%	-62.56%	70.95%	12.15%	-138.93%	5.11%	4.00%	33.58%	-1,812.36%	-46.85%
NOPAT Growth	-55.15%	-17.64%	-27.50%	55.40%	-61.96%	-160.91%	5.11%	-13.34%	7.68%	-1,080.54%	-44.93%
Net Income Growth	-55.46%	-22.43%	16.75%	-8.87%	-434.78%	108.85%	66.65%	-115.42%	-178.35%	-2,419.98%	-43.50%
EPS Growth	-55.63%	-22.39%	17.31%	-4.92%	-435.34%	123.91%	50.54%	-117.86%	-144.00%	-2,347.54%	-38.98%
Operating Cash Flow Growth	-21.24%	-18.71%	-11.42%	3.47%	-42.15%	130.58%	17.94%	-115.69%	341.65%	-15.92%	91.44%
Free Cash Flow Firm Growth	273.07%	111.25%	-140.43%	1,051.57%	-244.83%	97.91%	2,844.94%	-106.77%	-41.78%	-158.84%	155.53%
Invested Capital Growth	-2.34%	-11.26%	10.18%	-55.34%	198.17%	0.57%	-37.93%	2.69%	4.37%	-0.03%	-27.91%
Revenue Q/Q Growth	-16.48%	1.80%	-35.67%	48.48%	24.79%	-64.21%	201.32%	58.64%	2.79%	5.29%	0.66%
EBITDA Q/Q Growth	-15.59%	2.57%	-43.89%	37.07%	18.56%	-57.36%	56.86%	73.11%	39.35%	-359.89%	16.60%
EBIT Q/Q Growth	-18.75%	4.67%	-66.12%	107.24%	40.94%	-133.81%	53.54%	57.13%	53.26%	-834.80%	12.63%
NOPAT Q/Q Growth	-17.96%	0.63%	-35.83%	290.54%	-9.91%	-135.09%	53.54%	49.39%	25.45%	-564.57%	12.63%
Net Income Q/Q Growth	-16.60%	-3.78%	-12.84%	24.71%	-14.07%	1,344.79%	-31.23%	-144.73%	55.99%	-595.84%	13.37%
EPS Q/Q Growth	-19.76%	-3.70%	0.00%	0.00%	0.00%	0.00%	-39.39%	-160.98%	55.47%	-581.74%	14.61%
Operating Cash Flow Q/Q Growth	-9.68%	-2.59%	-15.80%	10.48%	-31.55%	26.69%	-8.38%	-173.20%	340.92%	21.28%	0.10%
Free Cash Flow Firm Q/Q Growth	-42.73%	52.90%	-244.40%	2,859.95%	-420.97%	75.94%	486.38%	-106.35%	19.88%	41.03%	-21.09%
Invested Capital Q/Q Growth	-3.35%	-8.93%	0.11%	-54.90%	13.22%	4.48%	-40.15%	2.24%	1.18%	-16.90%	-17.56%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	31.20%	31.15%	34.67%	33.26%	42.11%	53.86%	54.53%	55.62%	58.04%	56.02%	59.84%
EBITDA Margin	11.87%	11.74%	11.40%	13.38%	12.20%	16.07%	14.03%	10.20%	10.37%	-22.82%	-36.93%
Operating Margin	7.73%	7.43%	7.00%	6.91%	6.12%	-5.91%	-4.40%	-4.55%	-3.85%	-36.81%	-50.01%
EBIT Margin	7.73%	7.43%	4.58%	6.91%	5.11%	-5.91%	-4.40%	-3.86%	-2.35%	-36.34%	-50.03%
Profit (Net Income) Margin	5.45%	4.56%	8.75%	7.04%	-15.54%	4.08%	5.35%	-0.75%	-1.92%	-39.13%	-52.65%
Tax Burden Percent	85.82%	70.30%	349.07%	167.24%	-1,024.19%	-38.46%	-62.64%	568.34%	48.76%	100.23%	102.09%
Interest Burden Percent	82.12%	87.20%	54.77%	60.94%	29.70%	179.82%	193.92%	3.43%	167.63%	107.46%	103.10%
Effective Tax Rate	18.87%	25.07%	5.11%	-31.95%	62.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	4.76%	4.20%	3.08%	6.32%	1.95%	-0.79%	-0.93%	-1.35%	-1.20%	-13.93%	-23.46%
ROIC Less NNEP Spread (ROIC-NNEP)	2.45%	1.13%	8.43%	16.74%	-143.38%	3.20%	18.31%	-11.68%	2.26%	-45.03%	-53.37%
Return on Net Nonoperating Assets (RNNOA)	0.91%	0.37%	1.89%	-2.03%	-16.80%	2.09%	2.77%	1.06%	0.25%	-13.63%	-34.90%
Return on Equity (ROE)	5.66%	4.57%	4.97%	4.29%	-14.85%	1.29%	1.85%	-0.29%	-0.95%	-27.56%	-58.36%
Cash Return on Invested Capital (CROIC)	7.12%	16.13%	-6.60%	82.83%	-97.59%	-1.36%	45.88%	-4.00%	-5.48%	-13.90%	8.97%
Operating Return on Assets (OROA)	3.81%	3.62%	1.36%	2.27%	2.43%	-0.90%	-0.79%	-0.94%	-0.91%	-16.60%	-26.30%
Return on Assets (ROA)	2.68%	2.22%	2.60%	2.32%	-7.39%	0.62%	0.96%	-0.18%	-0.75%	-17.88%	-27.68%
Return on Common Equity (ROCE)	5.33%	4.30%	4.66%	4.03%	-14.30%	1.28%	1.83%	-0.29%	-0.95%	-27.54%	-58.30%
Return on Equity Simple (ROE_SIMPLE)	6.10%	5.01%	4.84%	4.72%	-15.03%	1.29%	1.65%	-0.34%	-0.96%	-32.19%	0.00%
Net Operating Profit after Tax (NOPAT)	215	177	129	200	76	-46	-44	-50	-46	-543	-787
NOPAT Margin	6.27%	5.57%	6.64%	9.12%	2.29%	-4.13%	-3.08%	-3.19%	-2.69%	-25.76%	-35.01%
Net Nonoperating Expense Percent (NNEP)	2.31%	3.08%	-5.34%	-10.42%	145.34%	-3.99%	-19.23%	10.33%	-3.47%	31.10%	29.91%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-1.33%	-1.17%	-13.76%	-27.64%
Cost of Revenue to Revenue	68.80%	68.85%	65.33%	66.74%	57.89%	46.14%	45.47%	44.38%	41.96%	43.98%	40.16%
SG&A Expenses to Revenue	21.79%	21.87%	25.84%	25.02%	34.02%	46.00%	46.68%	49.45%	48.64%	48.74%	47.60%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	3.06%	3.44%	3.89%	4.41%	4.33%	5.35%
Operating Expenses to Revenue	23.47%	23.72%	27.67%	26.35%	35.99%	59.77%	58.93%	60.17%	61.88%	92.83%	109.85%
Earnings before Interest and Taxes (EBIT)	266	237	89	152	170	-66	-63	-60	-40	-766	-1,125
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	408	374	221	293	406	180	200	159	177	-481	-830
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.94	1.52	1.39	0.75	1.24	1.28	1.54	0.84	0.89	0.96	1.02
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	2.14	0.00	0.00	4.65	8.19	13.29	0.00	0.00
Price to Revenue (P/Rev)	0.84	1.38	2.52	1.12	1.29	4.04	4.99	1.85	1.79	1.16	0.68
Price to Earnings (P/E)	17.26	34.40	32.28	17.47	0.00	106.27	99.30	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.79%	2.91%	3.10%	5.72%	0.00%	0.94%	1.01%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.96	1.43	1.31	1.93	1.14	1.17	2.37	0.85	0.91	0.97	1.01
Enterprise Value to Revenue (EV/Rev)	1.25	1.79	2.97	1.72	2.00	6.11	6.05	2.04	2.07	1.80	1.27
Enterprise Value to EBITDA (EV/EBITDA)	10.55	15.21	26.05	12.87	16.43	38.03	43.08	19.99	19.99	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	16.19	24.01	64.90	24.92	39.24	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	19.96	32.04	44.72	18.89	87.70	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.16	23.03	26.30	16.69	50.94	22.68	24.21	0.00	26.22	33.37	13.09
Enterprise Value to Free Cash Flow (EV/FCFF)	13.33	8.34	0.00	1.44	0.00	0.00	3.96	0.00	0.00	0.00	9.45
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.44	0.42	0.28	0.34	0.70	0.66	0.46	0.09	0.15	0.54	0.91
Long-Term Debt to Equity	0.43	0.42	0.28	0.34	0.69	0.65	0.46	0.03	0.15	0.53	0.88
Financial Leverage	0.37	0.33	0.22	-0.12	0.12	0.65	0.15	-0.09	0.11	0.30	0.65
Leverage Ratio	2.11	2.06	1.91	1.85	2.01	2.08	1.92	1.58	1.28	1.54	2.11
Compound Leverage Factor	1.73	1.80	1.05	1.13	0.60	3.74	3.73	0.05	2.14	1.66	2.17
Debt to Total Capital	30.33%	29.46%	22.16%	25.62%	41.23%	39.78%	31.49%	8.26%	13.08%	35.02%	47.59%
Short-Term Debt to Total Capital	0.12%	0.12%	0.12%	0.11%	0.47%	0.45%	0.11%	5.83%	0.00%	0.51%	1.23%
Long-Term Debt to Total Capital	30.20%	29.34%	22.04%	25.51%	40.77%	39.33%	31.38%	2.43%	13.08%	34.51%	46.36%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.99%	4.48%	4.74%	4.43%	0.81%	0.75%	0.65%	0.05%	0.06%	0.05%	0.08%
Common Equity to Total Capital	65.68%	66.06%	73.10%	69.95%	57.96%	59.47%	67.86%	91.70%	86.86%	64.93%	52.33%
Debt to EBITDA	3.48	3.45	4.80	4.08	6.03	13.17	10.71	1.95	2.91	-2.87	-1.63
Net Debt to EBITDA	2.99	2.90	2.94	3.82	5.76	12.63	7.31	1.80	2.70	-2.77	-1.59
Long-Term Debt to EBITDA	3.46	3.44	4.78	4.06	5.96	13.02	10.67	0.57	2.91	-2.83	-1.59
Debt to NOPAT	6.58	7.28	8.25	5.99	32.19	-51.17	-48.75	-6.23	-11.19	-2.55	-1.72
Net Debt to NOPAT	5.66	6.10	5.05	5.60	30.74	-49.07	-33.27	-5.75	-10.41	-2.46	-1.68
Long-Term Debt to NOPAT	6.55	7.25	8.20	5.96	31.82	-50.58	-48.57	-1.83	-11.19	-2.51	-1.68
Altman Z-Score	1.37	1.72	1.66	1.22	1.37	1.03	1.53	2.68	2.34	0.67	-0.34
Noncontrolling Interest Sharing Ratio	5.93%	6.03%	6.21%	6.02%	3.67%	1.31%	1.07%	0.56%	0.06%	0.07%	0.11%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.55	1.64	1.89	1.63	1.64	1.68	2.25	1.41	2.43	2.17	2.02
Quick Ratio	0.97	0.99	1.26	0.39	0.78	0.76	0.91	0.52	0.89	0.86	0.80
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	323	682	-276	2,622	-3,797	-79	2,179	-148	-209	-542	301
Operating Cash Flow to CapEx	434.78%	441.01%	460.17%	650.16%	111.33%	286.92%	366.34%	-54.39%	150.57%	62.81%	110.09%
Free Cash Flow to Firm to Interest Expense	6.79	22.51	-6.87	53.42	-31.78	-1.50	36.94	-3.32	-7.73	-9.49	8.64
Operating Cash Flow to Interest Expense	6.40	8.16	5.45	4.61	1.10	5.72	6.04	-1.26	4.98	1.99	6.24
Operating Cash Flow Less CapEx to Interest Expense	4.92	6.31	4.27	3.90	0.11	3.72	4.39	-3.57	1.67	-1.18	0.57
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.49	0.49	0.30	0.33	0.48	0.15	0.18	0.24	0.39	0.46	0.53
Accounts Receivable Turnover	3.58	3.69	2.14	3.23	7.02	2.08	3.70	5.99	6.11	6.03	5.29
Inventory Turnover	5.47	5.59	3.19	3.71	4.14	0.91	1.41	1.77	1.60	1.82	1.60
Fixed Asset Turnover	5.01	5.54	3.66	4.98	8.13	2.29	3.95	6.63	6.73	6.24	4.93
Accounts Payable Turnover	3.50	4.04	2.30	3.33	5.92	1.50	2.67	4.77	5.34	5.95	4.92
Days Sales Outstanding (DSO)	101.89	98.93	170.41	112.91	52.02	175.69	98.78	60.99	59.74	60.48	68.99
Days Inventory Outstanding (DIO)	66.67	65.35	114.57	98.41	88.22	401.09	259.20	205.96	228.11	200.04	228.73
Days Payable Outstanding (DPO)	104.26	90.27	158.99	109.52	61.67	243.55	136.61	76.51	68.30	61.35	74.11
Cash Conversion Cycle (CCC)	64.30	74.00	126.00	101.80	78.56	333.23	221.37	190.43	219.56	199.18	223.61
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,477	3,972	4,377	1,955	5,828	5,861	3,638	3,736	3,899	3,898	2,810
Invested Capital Turnover	0.76	0.75	0.46	0.69	0.86	0.19	0.30	0.42	0.45	0.54	0.67
Increase / (Decrease) in Invested Capital	-107	-504	404	-2,422	3,874	33	-2,223	98	163	-1.24	-1,088
Enterprise Value (EV)	4,301	5,687	5,754	3,777	6,671	6,848	8,622	3,186	3,539	3,788	2,844
Market Capitalization	2,895	4,407	4,878	2,449	4,284	4,530	7,115	2,898	3,058	2,452	1,524
Book Value per Share	$24.71	$23.62	$28.43	$27.90	$29.22	$29.91	$29.83	$63.68	$62.61	$45.86	$26.05
Tangible Book Value per Share	($5.98)	($3.02)	($0.45)	$9.76	($12.57)	($12.11)	$9.88	$6.53	$4.22	($8.02)	($8.14)
Total Capital	4,674	4,385	4,788	4,674	5,938	5,958	6,804	3,760	3,936	3,946	2,847
Total Debt	1,418	1,292	1,061	1,197	2,448	2,370	2,143	311	515	1,382	1,355
Total Long-Term Debt	1,412	1,287	1,055	1,192	2,421	2,343	2,135	91	515	1,362	1,320
Net Debt	1,220	1,083	649	1,120	2,339	2,273	1,463	286	479	1,334	1,318
Capital Expenditures (CapEx)	70	56	48	35	118	105	97	103	90	181	197
Debt-free, Cash-free Net Working Capital (DFCFNWC)	423	476	567	687	465	480	607	425	491	589	607
Debt-free Net Working Capital (DFNWC)	620	684	978	764	575	577	1,287	449	527	637	644
Net Working Capital (NWC)	615	679	972	759	547	550	1,280	230	527	617	609
Net Nonoperating Expense (NNE)	28	32	-41	45	593	-92	-120	-38	-13	282	397
Net Nonoperating Obligations (NNO)	1,220	879	649	-1,522	2,339	2,273	-1,023	286	479	1,334	1,318
Total Depreciation and Amortization (D&A)	142	137	132	142	236	246	263	220	217	285	294
Debt-free, Cash-free Net Working Capital to Revenue	12.31%	14.93%	29.25%	31.32%	13.97%	42.85%	42.57%	27.18%	28.74%	27.96%	27.01%
Debt-free Net Working Capital to Revenue	18.06%	21.48%	50.49%	34.84%	17.27%	51.51%	90.27%	28.73%	30.86%	30.25%	28.63%
Net Working Capital to Revenue	17.89%	21.31%	50.20%	34.61%	16.44%	49.09%	89.73%	14.70%	30.86%	29.30%	27.07%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.35	$1.04	$1.23	$1.16	($3.89)	$0.31	$0.47	$0.00	($0.61)	($14.93)	($20.75)
Adjusted Weighted Average Basic Shares Outstanding	122.75M	122.86M	123.33M	117.34M	118.15M	118.55M	161.33M	0.00	54.62M	56.96M	57.25M
Adjusted Diluted Earnings per Share	$1.34	$1.04	$1.22	$1.16	($3.89)	$0.31	$0.46	$0.00	($0.61)	($14.93)	($20.75)
Adjusted Weighted Average Diluted Shares Outstanding	122.75M	122.86M	123.33M	117.34M	118.15M	118.55M	161.33M	0.00	54.62M	56.96M	57.25M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	122.75M	122.86M	123.33M	117.34M	118.15M	118.55M	161.33M	0.00	54.62M	56.96M	57.25M
Normalized Net Operating Profit after Tax (NOPAT)	262	222	162	126	188	-35	-38	-63	-34	-72	-45
Normalized NOPAT Margin	7.64%	6.95%	8.37%	5.76%	5.66%	-3.09%	-2.66%	-4.06%	-1.98%	-3.44%	-2.01%
Pre Tax Income Margin	6.35%	6.48%	2.51%	4.21%	1.52%	-10.62%	-8.54%	-0.13%	-3.93%	-39.05%	-51.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.59	7.82	2.21	3.09	1.42	-1.25	-1.06	-1.36	-1.48	-13.41	-32.29
NOPAT to Interest Expense	4.54	5.86	3.21	4.07	0.64	-0.88	-0.75	-1.12	-1.70	-9.51	-22.60
EBIT Less CapEx to Interest Expense	4.12	5.97	1.03	2.38	0.44	-3.25	-2.71	-3.67	-4.79	-16.58	-37.96
NOPAT Less CapEx to Interest Expense	3.07	4.01	2.02	3.36	-0.35	-2.87	-2.39	-3.43	-5.01	-12.67	-28.27
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	-18.08%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	14.62%	14.33%	0.00%	129.47%	-18.08%	0.00%	0.00%	0.00%	0.00%	-0.58%	-0.30%

This table displays calculated financial ratios and metrics derived from Enovis' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/29/2023	12/31/2023	3/29/2024	6/28/2024	9/27/2024	12/31/2024	4/4/2025	7/4/2025	10/3/2025	12/31/2025	4/3/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	57,245,131.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	57,245,131.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.15
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.78%	11.33%	27.11%	22.56%	21.00%	23.29%	8.25%	7.50%	8.65%	2.64%	5.43%
EBITDA Growth	-13.57%	193.34%	-216.26%	48.88%	11.10%	-878.09%	64.42%	-0.34%	-1,318.53%	27.99%	257.30%
EBIT Growth	-123.78%	172.90%	-143.75%	31.90%	-59.79%	-3,554.02%	18.71%	-57.57%	-1,669.59%	24.47%	120.35%
NOPAT Growth	-14.36%	88.31%	-40.24%	-205.08%	-54.88%	-20,079.65%	-33.57%	62.02%	-1,659.74%	24.46%	-164.62%
Net Income Growth	95.73%	107.99%	-210.22%	-88.65%	-1,000.77%	-22,931.17%	22.46%	-97.43%	-1,726.22%	25.99%	84.83%
EPS Growth	95.94%	107.04%	-206.98%	-88.89%	-1,060.00%	-25,480.00%	25.76%	-88.24%	-1,622.41%	27.97%	84.69%
Operating Cash Flow Growth	59.78%	290.26%	-584.86%	-72.34%	72.69%	29.11%	95.59%	514.55%	54.18%	0.24%	1,600.69%
Free Cash Flow Firm Growth	-108.87%	-40.91%	-137.27%	-241.25%	-301.69%	-180.21%	164.71%	180.90%	203.71%	258.65%	88.68%
Invested Capital Growth	5.46%	4.37%	23.33%	20.25%	21.72%	-0.03%	-13.29%	-14.42%	-27.33%	-27.91%	-29.53%
Revenue Q/Q Growth	-2.56%	8.98%	13.46%	1.72%	-3.80%	11.04%	-0.38%	1.02%	-2.77%	4.89%	2.33%
EBITDA Q/Q Growth	-56.53%	112.34%	-169.63%	331.65%	-67.56%	-1,587.09%	103.94%	137.14%	-976.34%	12.12%	119.57%
EBIT Q/Q Growth	-29.44%	197.51%	-407.90%	82.48%	-203.72%	-2,007.68%	92.75%	66.03%	-3,311.00%	10.04%	101.95%
NOPAT Q/Q Growth	-41.38%	83.92%	-962.91%	-26.29%	28.23%	-1,994.56%	92.96%	64.09%	-3,225.13%	10.08%	75.36%
Net Income Q/Q Growth	71.06%	208.45%	-2,432.50%	74.23%	-68.87%	-2,149.38%	92.08%	34.39%	-1,462.09%	8.84%	98.38%
EPS Q/Q Growth	72.22%	200.00%	-2,740.00%	74.24%	-70.59%	-2,087.93%	92.28%	34.69%	-1,460.94%	8.51%	98.36%
Operating Cash Flow Q/Q Growth	10.35%	120.60%	-152.85%	121.50%	589.01%	64.93%	-101.81%	3,093.05%	72.87%	7.23%	-72.95%
Free Cash Flow Firm Q/Q Growth	10.33%	22.57%	-444.12%	9.68%	-5.56%	45.99%	225.65%	12.93%	35.33%	-17.37%	49.42%
Invested Capital Q/Q Growth	-0.31%	1.18%	18.85%	0.31%	0.90%	-16.90%	3.09%	-0.99%	-14.32%	-17.56%	0.76%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.19%	58.10%	57.70%	55.01%	56.70%	54.82%	59.45%	59.29%	59.92%	60.69%	62.04%
EBITDA Margin	8.56%	16.67%	-10.23%	23.30%	7.86%	-105.22%	4.16%	9.78%	-88.11%	-73.82%	14.11%
Operating Margin	-4.91%	-1.26%	-6.78%	-8.42%	-6.28%	-118.50%	-8.37%	-2.98%	-101.74%	-87.22%	1.11%
EBIT Margin	-4.73%	4.23%	-11.48%	-1.98%	-6.24%	-118.48%	-8.62%	-2.90%	-101.66%	-87.20%	1.66%
Profit (Net Income) Margin	-0.68%	0.68%	-13.92%	-3.53%	-6.19%	-125.35%	-9.97%	-6.47%	-104.01%	-90.39%	-1.43%
Tax Burden Percent	11.14%	40.22%	90.66%	67.68%	73.38%	104.37%	97.13%	142.47%	100.71%	102.14%	-1,332.81%
Interest Burden Percent	129.23%	39.79%	133.75%	263.43%	135.09%	101.36%	119.08%	156.81%	101.58%	101.50%	6.47%
Effective Tax Rate	0.00%	59.93%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1,426.66%
Return on Invested Capital (ROIC)	-1.52%	-0.23%	-2.06%	-2.65%	-2.06%	-44.84%	-2.91%	-1.06%	-39.28%	-40.92%	-9.78%
ROIC Less NNEP Spread (ROIC-NNEP)	1.98%	1.18%	-7.84%	-1.25%	-3.08%	-71.09%	-4.60%	-2.86%	-52.40%	-53.66%	-4.10%
Return on Net Nonoperating Assets (RNNOA)	0.19%	0.13%	-1.90%	-0.33%	-0.81%	-21.53%	-2.11%	-1.34%	-26.83%	-35.08%	-2.75%
Return on Equity (ROE)	-1.33%	-0.10%	-3.96%	-2.98%	-2.87%	-66.37%	-5.02%	-2.40%	-66.10%	-76.00%	-12.53%
Cash Return on Invested Capital (CROIC)	-6.96%	-5.48%	-22.16%	-20.13%	-21.50%	-13.90%	1.49%	3.20%	9.42%	8.97%	12.76%
Operating Return on Assets (OROA)	-1.78%	1.64%	-4.27%	-0.77%	-2.51%	-54.12%	-3.58%	-1.21%	-45.48%	-45.83%	0.87%
Return on Assets (ROA)	-0.26%	0.26%	-5.17%	-1.37%	-2.49%	-57.26%	-4.14%	-2.71%	-46.53%	-47.52%	-0.75%
Return on Common Equity (ROCE)	-1.33%	-0.10%	-3.95%	-2.98%	-2.86%	-66.32%	-5.02%	-2.40%	-66.03%	-75.92%	-12.51%
Return on Equity Simple (ROE_SIMPLE)	-2.16%	0.00%	-2.46%	-2.74%	-3.56%	0.00%	-30.89%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-14	-2.31	-25	-31	-22	-465	-33	-12	-391	-352	-87
NOPAT Margin	-3.44%	-0.51%	-4.75%	-5.89%	-4.40%	-82.95%	-5.86%	-2.08%	-71.22%	-61.05%	-14.70%
Net Nonoperating Expense Percent (NNEP)	-3.50%	-1.41%	5.79%	-1.40%	1.02%	26.25%	1.69%	1.80%	13.12%	12.74%	-5.69%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.06%	-	-	-	-11.79%	-0.81%	-0.29%	-11.36%	-12.35%	-3.02%
Cost of Revenue to Revenue	41.81%	41.90%	42.30%	44.99%	43.30%	45.18%	40.55%	40.71%	40.08%	39.31%	37.96%
SG&A Expenses to Revenue	48.92%	46.37%	49.53%	50.29%	49.45%	45.94%	48.14%	47.31%	48.03%	46.97%	48.00%
R&D to Revenue	4.77%	4.03%	4.53%	4.47%	4.06%	4.27%	5.10%	5.44%	5.42%	5.45%	5.35%
Operating Expenses to Revenue	63.10%	59.37%	64.48%	63.43%	62.98%	173.32%	67.82%	62.26%	161.67%	147.91%	60.93%
Earnings before Interest and Taxes (EBIT)	-20	19	-59	-10	-32	-665	-48	-16	-558	-502	9.80
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	36	76	-53	122	40	-590	23	55	-484	-425	83
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.84	0.89	1.03	0.75	0.73	0.96	0.71	0.75	0.91	1.02	0.88
Price to Tangible Book Value (P/TBV)	9.23	13.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.73	1.79	1.88	1.30	1.22	1.16	0.86	0.88	0.82	0.68	0.57
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.85	0.91	1.02	0.83	0.81	0.97	0.81	0.84	0.94	1.01	0.94
Enterprise Value to Revenue (EV/Rev)	1.98	2.07	2.61	2.01	1.90	1.80	1.51	1.52	1.44	1.27	1.16
Enterprise Value to EBITDA (EV/EBITDA)	25.89	19.99	33.60	21.21	20.52	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	107.46	26.22	51.82	54.07	40.57	33.37	21.98	17.67	14.82	13.09	10.92
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	50.36	24.04	8.44	9.45	6.06
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.13	0.15	0.42	0.42	0.42	0.54	0.55	0.56	0.70	0.91	0.94
Long-Term Debt to Equity	0.13	0.15	0.41	0.42	0.41	0.53	0.54	0.55	0.69	0.88	0.91
Financial Leverage	0.10	0.11	0.24	0.26	0.26	0.30	0.46	0.47	0.51	0.65	0.67
Leverage Ratio	1.29	1.28	1.45	1.47	1.47	1.54	1.75	1.78	1.86	2.11	2.12
Compound Leverage Factor	1.67	0.51	1.94	3.86	1.98	1.56	2.08	2.80	1.89	2.14	0.14
Debt to Total Capital	11.43%	13.08%	29.57%	29.78%	29.47%	35.02%	35.41%	35.84%	41.19%	47.59%	48.36%
Short-Term Debt to Total Capital	0.00%	0.00%	0.43%	0.32%	0.42%	0.51%	0.49%	0.50%	0.58%	1.23%	1.22%
Long-Term Debt to Total Capital	11.43%	13.08%	29.14%	29.46%	29.05%	34.51%	34.92%	35.34%	40.61%	46.36%	47.13%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.05%	0.06%	0.05%	0.05%	0.06%	0.05%	0.06%	0.07%	0.09%	0.08%	0.09%
Common Equity to Total Capital	88.52%	86.86%	70.38%	70.16%	70.47%	64.93%	64.53%	64.09%	58.73%	52.33%	51.55%
Debt to EBITDA	3.50	2.91	9.86	7.70	7.53	-2.87	-3.04	-3.05	-1.42	-1.63	-1.80
Net Debt to EBITDA	3.24	2.70	9.39	7.51	7.33	-2.77	-2.96	-2.96	-1.39	-1.59	-1.76
Long-Term Debt to EBITDA	3.50	2.91	9.72	7.62	7.42	-2.83	-3.00	-3.01	-1.40	-1.59	-1.75
Debt to NOPAT	-7.20	-11.19	-26.21	-18.89	-17.05	-2.55	-2.61	-2.71	-1.57	-1.72	-1.85
Net Debt to NOPAT	-6.68	-10.41	-24.96	-18.42	-16.61	-2.46	-2.54	-2.63	-1.54	-1.68	-1.80
Long-Term Debt to NOPAT	-7.20	-11.19	-25.83	-18.69	-16.80	-2.51	-2.57	-2.67	-1.55	-1.68	-1.80
Altman Z-Score	2.47	2.39	1.49	1.30	1.25	0.74	0.99	0.96	0.44	0.20	0.59
Noncontrolling Interest Sharing Ratio	0.05%	0.06%	0.06%	0.07%	0.07%	0.07%	0.08%	0.09%	0.11%	0.11%	0.12%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.40	2.43	2.10	2.26	2.27	2.17	2.55	2.25	2.22	2.02	2.04
Quick Ratio	0.87	0.89	0.81	0.83	0.82	0.86	0.99	0.88	0.81	0.80	0.78
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-214	-166	-901	-814	-859	-464	583	658	891	736	1,100
Operating Cash Flow to CapEx	114.73%	180.31%	-97.91%	19.73%	104.63%	166.06%	-3.69%	107.66%	154.37%	157.40%	45.36%
Free Cash Flow to Firm to Interest Expense	-37.08	-14.29	-45.07	-47.97	-77.64	-51.17	63.46	70.85	100.94	98.00	119.99
Operating Cash Flow to Interest Expense	5.38	5.91	-1.81	0.46	4.84	9.74	-0.17	5.14	9.35	11.79	2.61
Operating Cash Flow Less CapEx to Interest Expense	0.69	2.63	-3.65	-1.86	0.21	3.87	-4.88	0.37	3.29	4.30	-3.15
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.38	0.39	0.37	0.39	0.40	0.46	0.42	0.42	0.45	0.53	0.52
Accounts Receivable Turnover	6.20	6.11	5.49	5.52	5.91	6.03	5.27	5.16	5.37	5.29	5.18
Inventory Turnover	1.58	1.60	1.49	1.53	1.60	1.82	1.60	1.49	1.52	1.60	1.51
Fixed Asset Turnover	6.84	6.73	6.14	5.99	6.03	6.24	5.57	5.22	5.02	4.93	4.82
Accounts Payable Turnover	4.61	5.34	4.97	5.34	6.10	5.95	5.44	4.99	5.21	4.92	4.48
Days Sales Outstanding (DSO)	58.88	59.74	66.46	66.15	61.75	60.48	69.32	70.72	67.99	68.99	70.48
Days Inventory Outstanding (DIO)	230.55	228.11	244.93	237.95	228.24	200.04	228.72	244.32	240.10	228.73	241.03
Days Payable Outstanding (DPO)	79.14	68.30	73.48	68.34	59.79	61.35	67.12	73.07	70.03	74.11	81.48
Cash Conversion Cycle (CCC)	210.30	219.56	237.91	235.75	230.19	199.18	230.92	241.96	238.06	223.61	230.02
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,854	3,899	4,634	4,649	4,691	3,898	4,018	3,979	3,409	2,810	2,832
Invested Capital Turnover	0.44	0.45	0.43	0.45	0.47	0.54	0.50	0.51	0.55	0.67	0.67
Increase / (Decrease) in Invested Capital	200	163	877	783	837	-1.24	-616	-670	-1,282	-1,088	-1,187
Enterprise Value (EV)	3,290	3,539	4,735	3,842	3,797	3,788	3,254	3,323	3,217	2,844	2,651
Market Capitalization	2,876	3,058	3,409	2,479	2,437	2,452	1,853	1,922	1,830	1,524	1,296
Book Value per Share	$63.07	$62.61	$60.32	$59.92	$59.63	$45.86	$45.96	$45.13	$35.35	$26.05	$25.80
Tangible Book Value per Share	$5.71	$4.22	($9.38)	($8.16)	($8.23)	($8.02)	($8.08)	($9.54)	($8.37)	($8.14)	($7.47)
Total Capital	3,886	3,936	4,701	4,684	4,726	3,946	4,057	4,023	3,441	2,847	2,865
Total Debt	444	515	1,390	1,395	1,393	1,382	1,437	1,442	1,417	1,355	1,385
Total Long-Term Debt	444	515	1,370	1,380	1,373	1,362	1,417	1,422	1,397	1,320	1,350
Net Debt	412	479	1,323	1,360	1,357	1,334	1,398	1,398	1,384	1,318	1,352
Capital Expenditures (CapEx)	27	38	37	39	51	53	43	44	53	56	53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	467	491	555	635	657	589	722	688	691	607	633
Debt-free Net Working Capital (DFNWC)	499	527	622	670	693	637	761	732	725	644	666
Net Working Capital (NWC)	499	527	602	655	673	617	741	712	705	609	631
Net Nonoperating Expense (NNE)	-12	-5.39	47	-12	9.05	238	23	25	180	169	-78
Net Nonoperating Obligations (NNO)	412	479	1,323	1,360	1,357	1,334	1,398	1,398	1,385	1,318	1,352
Total Depreciation and Amortization (D&A)	55	57	6.43	133	71	74	71	72	74	77	73
Debt-free, Cash-free Net Working Capital to Revenue	28.10%	28.74%	30.56%	33.17%	32.85%	27.96%	33.59%	31.43%	30.94%	27.01%	27.78%
Debt-free Net Working Capital to Revenue	30.04%	30.86%	34.21%	34.99%	34.61%	30.25%	35.38%	33.44%	32.45%	28.63%	29.23%
Net Working Capital to Revenue	30.04%	30.86%	33.10%	34.21%	33.61%	29.30%	34.45%	32.53%	31.55%	27.07%	27.70%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.05	($1.32)	($0.34)	($0.58)	($12.69)	($0.98)	($0.64)	($9.99)	($9.14)	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	54.59M	54.62M	54.85M	55.85M	55.88M	56.96M	57.12M	57.16M	57.19M	57.25M	57.56M
Adjusted Diluted Earnings per Share	($0.05)	$0.05	($1.32)	($0.34)	($0.58)	($12.69)	($0.98)	($0.64)	($9.99)	($9.14)	($0.15)
Adjusted Weighted Average Diluted Shares Outstanding	54.59M	54.62M	54.85M	55.85M	55.88M	56.96M	57.12M	57.16M	57.19M	57.25M	57.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	54.59M	54.62M	54.85M	55.85M	55.88M	56.96M	57.12M	57.16M	57.19M	57.25M	57.56M
Normalized Net Operating Profit after Tax (NOPAT)	-11	-0.14	-15	-28	-19	-462	-30	-11	-5.70	-349	6.47
Normalized NOPAT Margin	-2.54%	-0.03%	-3.00%	-5.28%	-3.70%	-82.36%	-5.37%	-1.99%	-1.04%	-60.65%	1.10%
Pre Tax Income Margin	-6.11%	1.68%	-15.35%	-5.21%	-8.43%	-120.10%	-10.26%	-4.54%	-103.27%	-88.50%	0.11%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.42	1.66	-2.96	-0.61	-2.85	-73.29	-5.24	-1.76	-63.21	-66.82	1.07
NOPAT to Interest Expense	-2.49	-0.20	-1.23	-1.82	-2.01	-51.31	-3.56	-1.27	-44.28	-46.79	-9.45
EBIT Less CapEx to Interest Expense	-8.11	-1.61	-4.81	-2.93	-7.48	-79.15	-9.95	-6.53	-69.27	-74.31	-4.69
NOPAT Less CapEx to Interest Expense	-7.17	-3.47	-3.07	-4.15	-6.63	-57.17	-8.27	-6.04	-50.34	-54.28	-15.21
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-0.58%	0.00%	0.00%	0.00%	-0.30%	0.00%

Financials Breakdown Chart

Key Financial Trends

Enovis (NYSE: ENOV) shows a mixed but improving short-term picture, with revenue still growing, operating cash flow turning positive again in Q1 2026, and leverage remaining a key watch item. Over the last four years, the company has expanded sales meaningfully, but profitability has been volatile due to restructuring, amortization, and large one-time charges. The latest quarter suggests the business is generating cash from operations, even though reported earnings remain negative.

What looks constructive:

Revenue in Q1 2026 rose to $589.2 million, up from $575.8 million in Q4 2025 and $558.8 million in Q1 2025, showing continued top-line growth.
Gross profit in Q1 2026 increased to $365.5 million, with gross margin holding at roughly 62%, a solid level for the business.
Operating cash flow was positive $24.0 million in Q1 2026, a rebound from negative operating cash flow in Q1 2025 and a notable improvement versus the prior-year pattern.
Cash and equivalents increased to $33.1 million in Q1 2026 from $33.6 million in Q3 2025 and $38.5 million in Q1 2025, suggesting liquidity has remained fairly stable.
Total common equity improved to $1.48 billion in Q1 2026, up from $1.46 billion in Q4 2025 after a much stronger equity base in 2025 than in early 2024.
The company has been reducing debt somewhat in the long run from earlier levels, and recent quarters show more balanced financing activity rather than extreme dependence on borrowings.

Neutral observations:

Capital spending remains steady, with Q1 2026 property, plant and equipment purchases of $52.8 million, indicating continued investment in the business.
Research and development spending in Q1 2026 was $31.5 million, broadly in line with recent quarters, which supports product development but also limits near-term margins.
Share count has been relatively stable, with weighted average diluted shares around 57.6 million in Q1 2026 versus 56.9 million in Q4 2025.
The company’s balance sheet still includes significant goodwill and intangible assets, which are common for a medical/device platform but should be monitored for impairment risk.

What remains concerning:

Enovis reported a Q1 2026 net loss of $8.5 million, so profitability has not yet fully normalized.
Operating income in Q1 2026 was only $6.5 million, implying that core margins remain thin despite higher revenue.
Interest expense was $9.2 million in Q1 2026, which exceeds operating income and continues to pressure bottom-line results.
Total debt remains high at roughly $1.37 billion of long-term debt plus $35 million of short-term debt in Q1 2026.
The debt load is large relative to equity, and the company has needed ongoing financing activity over time, including debt issuance in several recent quarters.
Prior quarters included very large impairment and restructuring charges, especially in 2025, highlighting execution and integration risks.
Net income has been volatile over the last several years, ranging from modest profit in late 2023 to large losses in 2024 and 2025, which can make trend analysis difficult for investors.

Bottom line: Enovis appears to be showing early signs of operational recovery, especially in revenue and operating cash flow, but the company is still carrying heavy debt and has not yet produced consistent profitability. For retail investors, the key question is whether management can keep sales growing while converting more of that revenue into durable earnings and free cash flow.

06/03/26 11:29 PM ETAI Generated. May Contain Errors.

Enovis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Enovis' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Enovis' net income appears to be on an upward trend, with a most recent value of -$1.18 billion in 2025, falling from $187.18 million in 2015. The previous period was -$824.82 million in 2024. See where experts think Enovis is headed by visiting Enovis' forecast page.

Enovis' total operating income in 2025 was -$1.12 billion, based on the following breakdown:

Total Gross Profit: $1.35 billion
Total Operating Expenses: $2.47 billion

Over the last 10 years, Enovis' total revenue changed from $3.43 billion in 2015 to $2.25 billion in 2025, a change of -34.5%.

Enovis' total liabilities were at $2.34 billion at the end of 2025, a 8.7% increase from 2024, and a 32.6% decrease since 2015.

In the past 10 years, Enovis' cash and equivalents has ranged from $24.30 million in 2022 to $680.25 million in 2021, and is currently $36.39 million as of their latest financial filing in 2025.

Over the last 10 years, Enovis' book value per share changed from 24.71 in 2015 to 26.05 in 2025, a change of 5.4%.

Related Companies

Financial statements for NYSE:ENOV last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enovis (ENOV) Financials

Financials Breakdown Chart

Key Financial Trends

Enovis Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Enovis (ENOV) Financials

Annual Income Statements for Enovis

Quarterly Income Statements for Enovis

Annual Cash Flow Statements for Enovis

Quarterly Cash Flow Statements for Enovis

Annual Balance Sheets for Enovis

Quarterly Balance Sheets for Enovis

Annual Metrics And Ratios for Enovis

Quarterly Metrics And Ratios for Enovis

Financials Breakdown Chart

Key Financial Trends

Enovis Financials - Frequently Asked Questions

When does Enovis' financial year end?

How has Enovis' net income changed over the last 10 years?

What is Enovis' operating income?

How has Enovis' revenue changed over the last 10 years?

How much debt does Enovis have?

How much cash does Enovis have?

How has Enovis' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools